Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Harvard Business School
UBS
McKesson
Fuji
Argus Health

Generated: July 16, 2019

DrugPatentWatch Database Preview

Details for Patent: 8,865,698

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,865,698
Title:Method of treatment using substituted pyrazolo[1,5-a]pyrimidine compounds
Abstract: Provided herein are methods for treating pain, cancer, inflammation, neurodegenerative disease or Typanosoma cruzi infection in a mammal, which comprises administering to said mammal in need thereof a therapeutically effective amount of a compound of Formula I: ##STR00001## in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, X, Y and n have the meanings given in the specification.
Inventor(s): Haas; Julia (Boulder, CO), Andrews; Steven W. (Boulder, CO), Jiang; Yutong (Boulder, CO), Zhang; Gan (Niwot, CO)
Assignee: Array BioPharma Inc. (Boulder, CO)
Application Number:13/943,590
Prior Art and Litigation SupportOrder Prior Art and Litigation support for Patent 8,865,698
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 8,865,698

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bayer Hlthcare VITRAKVI larotrectinib CAPSULE;ORAL 210861-001 Nov 26, 2018 RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial METHOD OF TREATING CANCEROUS SOLID TUMORS ➤ Try a Free Trial
Bayer Hlthcare VITRAKVI larotrectinib CAPSULE;ORAL 210861-002 Nov 26, 2018 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial METHOD OF TREATING CANCEROUS SOLID TUMORS ➤ Try a Free Trial
Bayer Healthcare VITRAKVI larotrectinib SOLUTION;ORAL 211710-001 Nov 26, 2018 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial METHOD OF TREATING CANCEROUS SOLID TUMORS ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Chubb
Fuji
Healthtrust
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.